10.06.25 -- Accelerating Cell & Gene Therapies With End-To-End CDMO Solutions

We've supported over 1,000 clients in overcoming the hurdles of therapy development. Our commitment to innovation ensures that patients can access these groundbreaking therapies sooner.

Hear insights on what it takes to help solve the industry-wide capacity issue, and how one of the only global CDMOs is uniquely positioned to help immediately produce new CGT products.

Take a look behind the scenes and hear firsthand stories about the unwavering commitment to patients and clients driving gene therapy innovation.

Catalent’s UpTempo℠ AAV platform process is a scalable, cGMP-ready process for viral vector manufacturing that can reduce the current 18-20-month development timeline for drug product in half.

From plasmid design to vial-ready product, our proprietary AAVion® platform streamlines every step to accelerate your AAV program toward clinical success.

Rapidly advance your allogeneic development with a hypoimmunogenic iPSC platform that has pre-built TARGATT™ large knock-in technology.

Explore a variety of cell lines, high-performance cell culture media, and single-use bioreactors to suit your process needs for any cell type, no matter the scale or indication of your gene therapy.

With decades of cell and gene therapy expertise, our team delivers phase-appropriate designs, robust analyses, and thorough product characterization to ensure quality, suitability, and ROI.

We focus on selecting the right buffer and excipient combinations, conducting thorough stability testing, and confirming device compatibility and dosing procedures.

Leveraging a partner with expertise and integrated, end-to-end solutions can help overcome obstacles to increase patient access and ensure the safe distribution of your advanced therapy product.

Join 1,000+ pharma, biotech, and drug delivery professionals at the PODD: Partnership Opportunities in Drug Delivery Conference conference, October 27–28 in Boston. Featuring 10 technology tracks, pharma company spotlights, 1:1 partnering, and more. Attendees will also hear from leaders at companies including AbbVie, Amgen, AstraZeneca, Biogen, Eli Lilly, GSK, Moderna, Novartis, Pfizer, Regeneron, Roche, Sanofi, Takeda, and others. Register at PODDConference.com with code LSL20 for 20% off.